Mr. Hubert L. Allen

Executive Vice President, Gen. Counsel & Sec.

Mr. Scott Michael Leinenweber

Vice President of Investor Relations, Licensing & Acquisitions

Mr. Robert B. Ford

Chairman, Pres & Chief Executive Officer

Ms. Andrea F. Wainer

Executive Vice President of Rapid & Molecular Diagnostics

Ms. Melissa  Brotz

Vice President of Public Affairs & Corporation Marketing

Mr. Robert E. Funck Jr.

Executive Vice President of Fin. & Chief Financial Officer

Mr. Daniel Gesua Sive Salvadori

Executive Vice President and Group Pres of Established Pharmaceuticals & Nutritional Products

Ms. Elaine R. Leavenworth

Senior Vice President and Chief Marketing & External Affairs Officer

James E. Young

Vice President and Chief Ethics & Compliance Officer

Ms. Mary K. Moreland

Executive Vice President of HR

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Abbott Laboratories (ABT) receives FDA clearance for the integration of its iCGM system sensors with automated insulin delivery (AID) systems.

Abbott (ABT) to Pair CGM Sensors & AID System on FDA Clearance

PepsiCo and Abbott Laboratories both possess tremendous brand power. The two companies should continue to reward shareholders with rising dividends.

2 Top Dividend Stocks You Can Buy and Hold Forever

The 49 Dividend Kings started the new year on a positive note but cooled off in February, collectively losing 2.06%. The 11 best dividend kings selected for February, based on forecasted growth and valuation, outperformed the average dividend king return by 19 bps.

My 12 Best Dividend Kings For March 2023

Abbott's (ABT) Alinity i TBI lab test provides a new reliable result in 18 minutes to support clinicians in quickly assessing concussion and triaging patients.

Abbott (ABT) Gets FDA Nod for Alinity I Laboratory Test

Abbott Laboratories (ABT) demonstrates the superiority of the TriClip device in treating patients with severe, symptomatic tricuspid regurgitation.

Abbott (ABT) Reveals Favorable Data on Tricuspid Regurgitation

Abbott Laboratories to Acquire Cardiovascular Systems At Equity Value of $890M

Abbott Revenue Falls on Decline in Covid-Related Sales

Abbott Under Criminal Probe Over Baby Formula

Abbott Raises Guidance but Says Quarterly Sales Hit by Baby-Formula Shortage

Abbott Labs Raises Earnings Outlook as Revenue Climbs 

Abbott Boosts Guidance After Earnings Beat. But the Stock Is Falling.

Baby-Formula Production Restarts at Abbott Plant 

Latest Report of Baby’s Death After Consuming Formula Mentions Cronobacter Bacteria

FDA Investigating Report of Baby’s Death After Consuming Abbott Formula

Abbott Halts Production at Michigan Baby-Formula Plant 

Enfamil and Smaller Baby-Formula Brands Test Dominance of Similac

Abbott Labs reportedly aware of problems at baby-formula factory in Michigan months earlier than known

Abbott Received Earlier Warning on Formula Plant

Baby-Formula Shortage Expected to Persist Weeks Longer

FDA Chief Takes Aim at Abbott Laboratories 

Abbott to Release 300,000 Specialty Baby Formula Cans 

Why Is There a Baby Formula Shortage? What to Know and Why It’s Getting Worse

Abbott CEO Apologizes for Company’s Role in Baby-Formula Shortage

Gerber Owner Nestlé to Fly Extra Baby Formula to the U.S.

Baby Formula Shortage Could Leave Parents Scrambling for Months

Abbott Could Restart Baby Formula Production Within Two Weeks

Lucky Charms Sickness Complaints Spread Rapidly, Adding Complexity to Safety Probe 

Contaminated-Baby-Formula Investigation Turns Murky 

SoFi Technologies, AMC, Salesforce, Snowflake: What to Watch in the Stock Market Today

Abbott Recalls More Baby Formula

Abbott Recalls Baby Formula After Reports of Bacterial Contamination

Abbott’s Rapid Covid-19 Tests Boost Quarterly Sales Growth 

Tesla, Microsoft, Boeing, Texas Instruments: What to Watch in the Stock Market Today

Abbott Labs CEO Unveils Wearable Biosensors at CES

Novavax, Tesla, Netflix, United: What to Watch in the Stock Market Today

Abbott Labs Faces a Covid Setback. What to Know.

Abbott Warns Demand for Covid-19 Tests Is Dropping Fast

Kansas City Southern, IBM, United Airlines: What to Watch When the Stock Market Opens Today

Powered by AI

Abbott Laboratories

97.88